AmacaThera has been named Emerging Company of the Year by [...]

NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

Cereno Scientific has broadened the clinical development focus of its [...]

MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]

AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

MediciNova has completed patient enrollment in a Phase 2 clinical [...]

AmacaThera has entered an exclusive worldwide licensing agreement with Pacira [...]

Levicept Ltd will present new findings from its Phase 2 [...]

Acella Pharmaceuticals and Neuvosyn Laboratories have reported positive topline results [...]

FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]